Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Endometrial regeneration with mesenchymal stem cells and exosomes: an experimental rat model of intrauterine adhesions.

Atay F., Atay AO., Akdemir A., Uyanikgil Y., Eroglu E., Ercan G.

Animal Study with a reported sample of 5 on Systemic / IV, published in Sci Rep (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Sci Rep (2026)
Country
England
Reported sample size
5
Source database
PubMed
PMID
41888589
PMCID
PMC13172503
DOI
10.1038/s41598-026-45939-7

Abstract (original English)

Intrauterine adhesions (IUA) arise from inflammation-driven fibrotic remodeling that limits endometrial repair. Mesenchymal stem cells (MSCs) and MSC-derived exosomes are promising, but direct comparisons by tissue source and delivery route are limited. To compare umbilical cord (UC) and adipose-derived MSCs versus their exosomes and to assess local intrauterine versus intravenous (IV) UC-exosome delivery in a rat IUA model. Thirty-five female Sprague-Dawley rats were randomized (n = 5/group) to negative control, positive control (ethanol-IUA), and five treatment arms (local UC-MSC, UC-Exo, Adipose-MSC, Adipose-Exo, and IV UC-Exo). IUA was induced with 0.3 mL 95% ethanol; treatments were administered 2 weeks later. Two weeks after treatment, uterine tissues underwent H&E/Masson's trichrome evaluation, epithelial and wall thickness measurements, and blinded 0-3 scoring of inflammation, vascular proliferation, and fibrosis. Positive controls showed severe fibrosis and luminal narrowing. All treated groups demonstrated improved architecture and reduced collagen deposition versus positive controls. Epithelial thickness was higher in treated groups but did not differentiate treatment arms; only negative vs. positive controls differed (p < 0.001). Uterine wall thickness increased in all treatment groups versus positive controls (overall p < 0.006), and local and IV UC-Exo groups were

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsFemaleExosomesMesenchymal Stem CellsRatsEndometriumTissue AdhesionsDisease Models, AnimalRats, Sprague-DawleyMesenchymal Stem Cell Transplantation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research